Penny stock under Rs 60 hit a 5 per cent lower circuit after announcing a 1:1 bonus share

On Wednesday, shares of Hamps Bio Ltd hit a 5 per cent lower circuit to Rs 55.25 per share from its previous closing of Rs 58.15 per share. The stock has a 52-week high of Rs 107.20 per share and a 52-week low of Rs 34.21 per share.

The Hamps Bio Ltd. Board has recommended a 1:1 bonus share issue, meaning shareholders will receive one new equity share of Rs 10 for every share they currently hold. This issuance, totalling approximately Rs 4.36 crore (43.56 lakh shares), will be funded from the company's free reserves and/or securities premium as of March 31, 2025. Following the bonus issue, the paid-up share capital will double from Rs 4.36 crore to Rs 8.71 crore. The company expects to credit or dispatch these bonus shares by September 28, 2025.

Incorporated in 2007, Hamps Bio Limited specialises in the pharmaceutical formulation and freeze-drying ingredient sectors. The company ethically markets and distributes a wide range of pharmaceutical formulations, including tablets, syrups, capsules, and injectables, sourced from WHO GMP-approved manufacturers. Additionally, through its FDFP (Freeze Dried and Frozen Products) vertical, operating under the brand "FzyEzy," Hamps Bio manufactures and distributes freeze-dried fruits, vegetables, herbs, and flowers, catering to both B2B and B2C markets, with significant export operations.

In FY25, the company reported net sales of Rs 6.67 crore and net profit of Rs 0.30 crore. The company has a market cap of Rs 24 crore. The shares of the company have a PE of 80x, an ROE of 5 per cent and an ROCE of 7 per cent. The stock is up by 62 per cent from its 52-week low of Rs 34.21 per share.

Disclaimer: The article is for informational purposes only and not investment advice.